Remember too we have the United European Gastroenterology Week coming up next month, where Immuron will present the final preclinical colitis data, which as per the press release below, sounds like is quite promising.
https://globenewswire.com/news-rele...-Colitis-Symptoms-in-Preclinical-Program.html
Preclinical yes but IBD is another huge market and just another piece of Immuron's value.
Remember too we have the United European Gastroenterology Week...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
